NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

Completed · Not applicable

Conditions studied: Cardiac Arrest, Cardiopulmonary Arrest, Cardiovascular Diseases

In brief

The NEURESCUE device is the first intelligent catheter for aortic balloon occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body. The objective of this study is to investigate the feasibility of the NEURESCUE device as an adjunct to Advanced Cardiac Life Support (ACLS) in adults with cardiac arrest.

Key facts

Study ID

NCT05444049

Run by

neurescue

People needed

6

Starts

2022-12-08

Expected to finish

2024-09-30

Last updated by the study team

2025-10-09

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥18 and ≤80 years
• CPR initiated within 7 min of presumed arrest
• 8 min of continuous ACLS without ROSC

You may not qualify if…

• Traumatic cardiac arrest
• Intraoperative cardiac arrest
• Known pregnancy
• Known terminal disease
• Known do-not-attempt-CPR order
• Subjects whose femoral arterial access site cannot accommodate an 8 Fr introducer sheath
• Subjects currently on mechanical circulatory support

Where it is running

• Long Beach Medical Center — Long Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.